Category:
Description:
Indications:
Contraindications:
-
Hyperthyroidism,
moderate to severe hypertension, glaucoma, sever arteriosclerosis
-
History
of drug abuse, symptomatic cardiovascular disease, agitated states,
within 14 days of MAOI
administration
Precautions:
-
Pregnancy
category C; use for medical conditions does not pose significant risk
to the fetus for congenital anomalies, but mild withdrawal symptoms
may be observed in newborn children ; contraindicated during breast
feeding
-
Mild
hypertension, child <3 years, Tourette’s disorder
-
Motor
and phonic tics
-
Tartrazine
sensitivity (15mg sustained release preparation)
Adverse
Reactions (Side Effects):
-
CNS:
addiction, aggressiveness, changes in libido, chills, dependence,
dizziness, dyskinesia, dysphoria, euphoria, headache, hyperactivity,
insomnia, irritability, over-
stimulation, psychotic episodes, restlessness, talkativeness, tremor
-
CV:
arrhythmias (at large doses), dysrhythmias, hypertension,
palpitations, reflex decrease in heart rate, tachycardia
-
GI:
anorexia, constipation, cramps, diarrhea, dry mouth, metallic taste,
nausea, vomiting, weight loss
-
GU:
impotence
-
METAB:
reversible elevations in serum thyroxine with heavy use
-
SKIN:
urticaria
|
Dosage:
Administered
orally
-
Adult:
-
Child:
-
Attention
deficit disorder with hyperactivity: PO 5mg 1-2 times daily
initially, increase in increments of 5 mg/day at weekly intervals
until an optimum response is achieved; usual effective dose
20-25mg daily (divided twice daily with conventional tablets or
once daily with sustained release formulations)
Drug
interactions:
-
MAOIs:
severe hypertensive reactions possible
-
Selegiline:
Potential for enhanced pressor effect if used in combination
-
Sodium
bicarbonate (large doses): inhibit elimination and increase the effect
of amphetamines
|
The information contained here is an abbreviated summary. For more detailed
and complete information, consult the manufacturer's product information sheets
or standard textbooks. Source:
Operational Medicine 2001, Health
Care in Military Settings, NAVMED P-5139, May 1, 2001, Bureau
of Medicine and Surgery, Department
of the Navy, 2300 E Street NW, Washington, D.C., 20372-5300
OB-GYN 101:
Introductory Obstetrics & Gynecology
© 2003, 2004, 2005, 2008
Medical Education Division,
Brookside Associates, Ltd.
All rights reserved
|